Project Grant K99DE036046
- The National Institute of Dental and Craniofacial Research, an operating division of the Department of Health and Human Services National Institutes of Health, awarded Regents of the University of Michigan $600,214 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to define the neuronal basis of odontogenic pain and identify targets for non-opioid analgesic development. The project, led by Dr. Joshua Emrick, investigates the cells, circuits, and behavioral...
- The National Institute of Dental and Craniofacial Research awarded New York University $656,068 on August 3, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to fund research into the neuronal mechanisms of lingual mechanosensation and nociception. The research investigates the molecular identities and functional roles of oral mechanosensory neurons and their contributions to oral health and pain disorders. The work focuses on tongue-innervating trigeminal neurons and...
- The National Institute of Dental and Craniofacial Research awarded Brigham and Women's Hospital Inc. $694,824 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop targeted gene delivery strategies for trigeminal neuralgia treatment. The project will identify trigeminal nociceptor subtypes that drive chronic facial pain in trigeminal neuralgia using nociceptor-specific transgenic mouse lines in a validated disease model, then develop a novel gene...
- The National Institute of Dental and Craniofacial Research awarded a cooperative agreement of $571,544 to The Regents of the University of California, San Francisco on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct a pivotal Phase III multi-site clinical trial of high-frequency repetitive transcranial magnetic stimulation at the primary motor cortex for trigeminal neuropathic pain. The trial evaluates the safety, efficacy, and durability of...
- The National Institute of Dental and Craniofacial Research awarded Duke University $444,125 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate central nervous system and autonomic correlates of temporomandibular disorder pain. The research characterizes how altered brainstem circuit activity and brain glymphatic flow relate to autonomic dysfunction in patients with chronic painful temporomandibular disorder (TMD). The project measures...
- The National Institute of Dental and Craniofacial Research awarded Brigham & Women's Hospital Inc. $160,704 on September 12, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop a viral gene therapy strategy for treating chronic craniofacial and dental pain caused by trigeminal nociceptor activation. The funded research will identify gene enhancers uniquely active in trigeminal ganglion nociceptors and functionally screen adeno-associated viruses (AAVs)...
- The National Institute of Dental and Craniofacial Research awarded the Regents of the University of Michigan $583,620 on August 21, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to engineer transfer RNA-derived small RNAs (tsRNAs) as species-specific antimicrobial agents targeting oral pathobionts. The funded work develops chemically modified tsRNAs to suppress dental pathogens including Fusobacterium nucleatum, Porphyromonas gingivalis, and Treponema denticola while...
- The National Institute of Dental and Craniofacial Research awarded Trustees of Boston University $249,000 on May 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate neutrophil-sensory neuron interactions in dental pulp inflammation and pain. The research addresses pulpitis, an inflammatory disease of the dental pulp currently managed through invasive procedures such as root canal therapy and tooth extraction. The project examines how neutrophils drive...
- The National Institute of Dental and Craniofacial Research awarded the Regents of the University of Minnesota $308,000 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate DNA methylation signatures as clinical biomarkers in temporomandibular disorders and chronic pain conditions. The project addresses clinical heterogeneity in temporomandibular disorders (TMDs), where patients reporting identical pain intensity exhibit dramatically different...
- The National Institute of Dental and Craniofacial Research awarded The Ohio State University $690,195 on March 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate neuroimmunological mechanisms regulating reparative dentinogenesis in response to deep tooth injuries and inflammation. The project examines how calcitonin gene-related peptide (CGRP) derived from sensory neurons regulates immune and mineralizing cell responses during tooth healing, specifically...
The National Institute of Dental and Craniofacial Research awarded the Regents of the University of Michigan $135,000 on August 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support research dissecting the neural and molecular mechanisms of trigeminal low-temperature sensation. The funded research addresses orofacial neuropathic pain stemming from somatosensory nervous system dysregulation, including cold allodynia and cold hyperalgesia in conditions such as chemotherapy-induced neuropathy and trigeminal neuralgia. Current treatments fail to alleviate these cold-sensation symptoms because the underlying cellular and molecular mechanisms for low-temperature sensation remain poorly defined. The investigator will employ intersectional genetic strategies in mice, combining thermoelectric cooling probes, in vivo trigeminal functional imaging, multiplexed in situ hybridization, neural tracing, and artificial intelligence-based behavioral analyses to delineate the neural and molecular logic underlying low-temperature sensation. Preliminary data reveal that CHRNA7+ trigeminal A-delta nociceptors encode noxious cold sensation in teeth independently of the canonical cool receptor TRPM8, providing evidence that low-temperature encoding is distributed across multiple trigeminal classes. The work will define molecular and neural mechanisms underlying orofacial low-temperature sensation and characterize behavioral outputs and central projections of low-temperature-encoding trigeminal populations using optogenetics and machine learning. Performance occurs at the University of Michigan, Ann Arbor, Michigan, with a period of performance from August 1, 2026, through July 31, 2028. The award is classified as a project grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $135.0k | 7/20/26 |